UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Biopharma stocks listed in H1 perform poorer than non-pharma peers
Pharmaceutical and biotech companies listed in the first half marked a slow...
by Nam Doo-hyun
|
2018-07-03 15:08
라인
‘Government support for dementia tests might be ill-timed’
The Moon Jae-in administration has vowed to boost support for state dementi...
by Nam Doo-hyun
|
2018-07-03 11:47
라인
‘Bleeding risk lowest in Eliquis among NOACs for AF patients’
Eliquis (ingredient: apixaban) by Bristol-Myers Squibb Korea and Korea Pfiz...
by Nam Doo-hyun
|
2018-07-02 16:47
라인
BMS Korea wins fight for Eliquis patent
Bristol-Myers Squibb (BMS) Korea said it has won a suit against domestic dr...
by Nam Doo-hyun
|
2018-06-29 14:41
라인
Prognostic marker for childhood obesity complications wins patent
A new biomarker in urine to predict childhood obesity complications might b...
by Nam Doo-hyun
|
2018-06-27 12:19
라인
Antarctic sea microorganisms; a solution to blood shortage?
The Korean government has developed a technology to freeze human blood usin...
by Nam Doo-hyun
|
2018-06-26 14:44
라인
Korea’s drug exports to US, Europe on the rise
Korea’s pharmaceutical exports to the U.S. and Europe have expanded over th...
by Nam Doo-hyun
|
2018-06-25 16:09
라인
Chong Kun Dang topped in H1 clinical trial
Chong Kung Dang, a local pharmaceutical firm, beat multinational rivals by ...
by Nam Doo-hyun
|
2018-06-21 11:11
라인
Over 60% of KOSDAQ biotech firms mark falls in Q1 operating profit
More than 60 percent of biotech companies listed on KOSDAQ suffered operati...
by Nam Doo-hyun
|
2018-06-19 11:43
라인
‘Medytox botulinum toxin worth 600 billion won in China’
Neuronox, the botulinum toxin developed by Medytox that is seeking China’s ...
by Nam Doo-hyun
|
2018-06-19 09:26
라인
Will SGLT-2 inhibitors win more antidiabetic prescriptions?
The pharmaceutical industry is actively discussing merits of sodium-glucose...
by Nam Doo-hyun
|
2018-06-15 11:58
라인
Highlights of US cancer meet: immunotherapy, gastrointestinal cancer
Immunotherapies and gastrointestinal cancer drew the most attention during ...
by Nam Doo-hyun
|
2018-06-14 15:51
라인
Dongkook, Chong Kun Dang most popular in functional foods
Dongkook Pharmaceutical, Chong Kung Dang Healthcare, and Sanofi-Aventis Kor...
by Nam Doo-hyun
|
2018-06-12 11:19
라인
Drugmakers unveil new clinical data at US cancer meet
Korean and global pharmaceutical companies disclosed their newest clinical ...
by Nam Doo-hyun
|
2018-06-08 14:41
라인
Gilead successfully switches HIV drug to Genvoya
Gilead Sciences Korea seems to have successfully switched its key drug in H...
by Nam Doo-hyun
|
2018-06-07 15:11
라인
‘Tug-of-war in Lipiodol pricing only hurts patients’
Guerbet Korea has recently come under fire for threatening to stop the supp...
by Nam Doo-hyun
|
2018-06-05 15:23
라인
‘Baxter’s Theranova dialyzer better than conventional devices’
Baxter’s Theranova, a blood filter for artificial kidneys, can be more effe...
by Nam Doo-hyun
|
2018-05-30 14:29
라인
Korea to review cost-effectiveness of PCV of Pfizer, GSK
The health authorities said they would start analyzing the cost-effectivene...
by Nam Doo-hyun
|
2018-05-25 15:59
라인
Korea exported drugs to Europe the most in first 4 months
Korea exported pharmaceutical products to Europe the most and medical devic...
by Nam Doo-hyun
|
2018-05-24 15:31
라인
Reyon’s suit against ViroMed dismissed over VM202 rights
A recent court decision took a massive blow to Reyon Pharmaceutical, which ...
by Nam Doo-hyun
|
2018-05-24 11:38
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top